Productions of artificial tissues by means of tissue engineering using agarose-fibrin biomaterials
OwnerMiguel Alaminos Mingorance, José Ignacio Muñoz Ávila +3inventors
InventorsMiguel Alaminos Mingorance, José Ignacio Muñoz Ávila, Miguel González Andrades, Antonio Campos Muñoz, Ingrid Johanna Garzón Bello
Life of this patent
Estimating the term…
Abstract
The present invention is encompassed in the field of biomedicine and more specifically tissue engineering. It relates specifically to an in vitro method for preparing an artificial tissue, to the artificial tissue obtainable by said method and to the use of this artificial tissue to partially or completely increase, restore or replace the functional activity of a damaged tissue or organ.
Claims28
An in vitro method for preparing an artificial tissue comprising:
- a) adding a composition comprising fibrinogen to a sample of isolated cells,
- b) adding an antifibrinolytic agent to the product resulting from step (a),
- c) adding at least one coagulation factor, a source of calcium, thrombin, or any combination of the above to the product resulting from step (b),
- d) adding a composition of a polysaccharide to the product resulting from step (c),
- e) culturing isolated cells in or on the product resulting from step (d), and
- f) inducing the nanostructuring of the product resulting from step (e).
(canceled)
(canceled)
7-8. (canceled)
(canceled)
15-18. (canceled)
An artificial tissue obtained by an in vitro method comprising:
- a) adding a composition comprising fibrinogen to a sample of isolated cells,
- b) adding an antifibrinolytic agent to the product resulting from step (a),
- c) adding at least one coagulation factor, a source of calcium, thrombin, or any combination of the above to the product resulting from step (b),
- d) adding a composition of a polysaccharide to the product resulting from step (c),
- e) culturing isolated cells in or on the product resulting from step (d), and
- inducing the nanostructuring of the product resulting from step (e).
A method, for evaluating a pharmacological and/or chemical product comprising:
- i) contacting a pharmacological and/or chemical product with an artificial tissue obtained by an in vitro method for preparing an artificial tissue comprising:
- a) adding a composition comprising fibrinogen to a sample of isolated cells,
- b) adding an antifibrinolytic agent to the product resulting from step (a),
- c) adding at least one coagulation factor, a source of calcium, thrombin, or any combination of the above to the product resulting from step (b),
- d) adding a composition of a polysaccharide to the product resulting from step (c),
- e) culturing isolated cells in or on the product resulting from step (d), and
- f) inducing the nanostructuring of the product resulting from step (e);
- ii) observing the reaction produced by the pharmacological and/or chemical product in said artificial tissue;
- and
- iii) deciding if the pharmacological and/or chemical product is suitable for animal testing.
(canceled)
30-37. (canceled)
39-90. (canceled)
Dependencies are inferred from the claim text.